Candriam S.C.A. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 94 filers reported holding CTI BIOPHARMA CORP in Q4 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2015$1,863,000
-15.8%
1,515,0000.0%0.05%
-7.4%
Q3 2015$2,212,000
-21.5%
1,515,000
+4.8%
0.05%
-8.5%
Q2 2015$2,818,000
+7.7%
1,445,0000.0%0.06%
+11.3%
Q1 2015$2,616,000
-1.5%
1,445,000
+28.4%
0.05%
-5.4%
Q4 2014$2,655,0001,125,0000.06%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2015
NameSharesValueWeighting ↓
PYRRHO CAPITAL MANAGEMENT, LP 608,194$1,186,0000.58%
Lombard Odier Asset Management (USA) Corp 2,768,341$5,398,0000.38%
Rotella Capital Management, Inc. 43,666$85,0000.07%
TWO SIGMA SECURITIES, LLC 19,994$39,0000.06%
OXFORD ASSET MANAGEMENT LLP 1,214,227$2,368,0000.06%
Candriam S.C.A. 1,445,000$2,818,0000.06%
WASHINGTON TRUST Co 410,616$801,0000.05%
DRW Securities, LLC 250,000$488,0000.05%
GLOBEFLEX CAPITAL L P 120,000$234,0000.04%
First Heartland Consultants, Inc. 74,624$146,0000.04%
View complete list of CTI BIOPHARMA CORP shareholders